ESCRS 2023: Presbyopia treatment with microporation therapeutic technology by Ace Vision Group
AnnMarie Hipsley, DPT, PhD, met with Ophthalmology Times Europe to discuss Ace Vision Group's microporation therapeutic technology, used to treat presbyopia.
Global study reveals new key genetic targets linked to glaucoma risk
Hundreds of previously-unknown genes could be vital for early detection and treatment.
Ciliatech presents data on first-generation implant at World Glaucoma Congress
Preliminary results indicate significant improvement for patients and ‘very good safety profile’
2 Clarke Drive Cranbury, NJ 08512